UPDATE: AngioDynamics (ANGO) Tops Q3 EPS by 1c; Cuts FY EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Piper Jaffray Assumes AngioDynamics (ANGO) at Neutral
April 8, 2016 6:38 AM EDTPiper Jaffray assumes coverage on AngioDynamics (NASDAQ: ANGO) with a Neutral rating and a price target of $12.00.
Analyst Brooks West commented, "We are assuming coverage of AngioDynamics, Inc. with a Neutral rating and $12 PT. ANGO reported fiscal 3Q16 earnings this evening and... More
